Company profile for Excella GmbH

PharmaCompass
Related CompaniesRelated Companies

About

Since beginning of 2008 Excella is part of FAREVA, one of the top contract manufacturing organizations in Europe today covering services in four fields – Home Care & Industrial, Cosmetics, Pharmaceuticals and Food. FAREVA’s Pharma Division provides you with a full service, ranging from pharmaceutical and chemical development, pilot scale manufacturing, supply of clinical studies till industrial-scale production, packaging and quality control. Eight different pharmaceutical sites located throughout Europe serve your needs for practically all marketed dosage forms as well as API’s.

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Nürnberger Strasse 12 90537 FEUCHT
Telephone
Telephone
+49 91284040
youtube
YouTube
Twitter
Twitter
Contact Info
Others

Events

Webinars & Exhibitions

Default Event

CPhI North America

Not Confirmed

envelop Contact Supplier

CPhI North America

Post an Enquiry

Meeting

Digital content read-more

Explore the latest content creation from this company

NEWS #PharmaBuzz

read-more
read-more

https://www.excella.de/titel-des-artikels-3-3-2/

PRESS RELEASE
28 Jul 2023
What role does calcium hydrogen phosphate play in the tamoxifen bottleneck?
What role does calcium hydrogen phosphate play in the tamoxifen bottleneck?

11 May 2022

// Brigitte M Gensthaler PHARMAZEUTISCHE

https://www.pharmazeutische-zeitung.de/welche-rolle-spielt-calcium-hydrogenphosphat-beim-tamoxifen-engpass-133072/

Brigitte M Gensthaler PHARMAZEUTISCHE
11 May 2022

https://www.fareva.com/en/news/fareva-excella-augmente-ses-capacites-de-production-de-produits-hautement-actifs

PRESS RELEASE
11 May 2021

https://extrajournal.net/2021/04/28/fareva-uebernimmt-novartis-standort-mit-wolf-theiss/

EXTRAJOURNALS
28 Apr 2021

https://bioprocessintl.com/bioprocess-insider/facilities-capacity/fareva-to-grow-its-newly-acquired-biomanufacturing-capabilities/

BIOPROCESSINTL
20 Apr 2021
France ramps up COVID-19 vaccine production
France ramps up COVID-19 vaccine production

10 Feb 2021

// Rachel Arthur BIOPHARMAREPORTER

https://www.biopharma-reporter.com/Article/2021/02/10/France-ramps-up-COVID-19-vaccine-manufacturing

Rachel Arthur BIOPHARMAREPORTER
10 Feb 2021

Inspections and registrations

Check the inspections & registration from this company

FDA

read-more
read-more

01

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : Germany

Zip :

District :

Center :

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2022-10-19

Fareva Company Banner

02

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2019-07-12

Fareva Company Banner

03

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2017-03-17

Fareva Company Banner

04

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CVM

Project Area : Monitoring of Marketed Animal Dr...

District Decision : No Action Indicated

Inspection End Date : 2017-03-17

Fareva Company Banner

05

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CVM

Project Area : Monitoring of Marketed Animal Dr...

District Decision : No Action Indicated

Inspection End Date : 2015-05-29

Fareva Company Banner

06

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2015-05-29

Fareva Company Banner

07

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CVM

Project Area : Monitoring of Marketed Animal Dr...

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-05-17

Fareva Company Banner

08

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2013-05-17

Fareva Company Banner

09

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : Voluntary Action Indicated

Inspection End Date : 2012-10-10

Fareva Company Banner

10

FDA Audited

USA

Excella GmbH

City : Feucht

State :

Country/Area : DE

Zip :

District : ORA

Center : CDER

Project Area : Drug Quality Assurance

District Decision : No Action Indicated

Inspection End Date : 2010-03-12

Fareva Company Banner
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Contact Excella GmbH and get a quotation

Excella GmbH is a supplier offers 7 products (APIs, Excipients or Intermediates).

Find a price of Tamoxifen Citrate bulk with JDMF offered by Excella GmbH

Find a price of Bicalutamide bulk offered by Excella GmbH

Find a price of Deracoxib bulk offered by Excella GmbH

Find a price of Firocoxib bulk offered by Excella GmbH

Find a price of Talazoparib Tosylate bulk offered by Excella GmbH

Find a price of Taurolidine bulk offered by Excella GmbH

Find a price of Temozolomide bulk offered by Excella GmbH

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty